XCUR Exicure Inc — Stock Price and Discussion | Stocktwits. Exicure Inc NASDAQ Updated Jul 15, 2021 8:00 PM. XCUR 1.42 0.05 (3.40%) 1,075. Key Data. 52wk Low 1.37. 52wk High 2.83.

Exicure's stock was trading at $1.66 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XCUR shares have decreased by 14.5% and is now trading at $1.42. View which stocks have been most impacted by COVID-19. What price target have analysts set for XCUR?

XCUR | Complete Exicure Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

What this means: InvestorsObserver gives Exicure Inc (XCUR) an overall rank of 35, which is below average. Exicure Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.

Shares of Exicure XCUR, -4.65% are up 26% in premarket trading on the news that the biotechnology company entered into an agreement with Allergan AGN, -0.20% to develop treatments for hair loss disorders. 1 year ago - Market Watch

Analyst Price Target on XCUR. Based on 2 Wall Street analysts offering 12 month price targets for Exicure in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 322.54% change from the last price of $1.42. The highest, average, and lowest price ...

The Exicure, Inc. stock price fell by -1.34% on the last day (Tuesday, 13th Jul 2021) from $1.49 to $1.47. and has now fallen 3 days in a row. During the day the stock fluctuated 3.40% from a day low at $1.47 to a day high of $1.52. The price has fallen in 6 of the last 10 days and is down by -8.13% for this period.

Our Science. Our SNA technology enables delivery of genetically-targeted therapies to a broad range of tissues and cells. We have shown potential application in preclinical studies in the CNS, eye, lung and the GI tract. Learn more about how our SNA technology works. LEARN MORE.